Influenza Research News
-
Rapid Influenza Diagnostics Market Development by Companies ... - KaleidoScot
Jun 5, 2023 | 14:22 pmRapid Influenza Diagnostics Market Development by Companies ... KaleidoScot
Read more... -
Novavax Announces Agreement with Bill & Melinda Gates Medical ... - PR Newswire UK
Jun 5, 2023 | 14:00 pmNovavax Announces Agreement with Bill & Melinda Gates Medical ... PR Newswire UK
Read more... -
Influenza Diagnostics Market 2023 Future Outlook: Emerging Trends ... - KaleidoScot
Jun 5, 2023 | 11:19 amInfluenza Diagnostics Market 2023 Future Outlook: Emerging Trends ... KaleidoScot
Read more... -
Aussies hit with numerous flus, Covid-19 as expert notes disturbing trend - Daily Mail
Jun 5, 2023 | 07:55 amAussies hit with numerous flus, Covid-19 as expert notes disturbing trend Daily Mail
Read more... -
For These Bird Flu Researchers, Work Is a Day at the Very 'Icky' Beach - The New York Times
Jun 4, 2023 | 11:00 amFor These Bird Flu Researchers, Work Is a Day at the Very 'Icky' Beach The New York Times
Read more... -
A World Leader in Influenza Vaccines | CSL Seqirus - CSL Limited
Jun 1, 2023 | 13:56 pmA World Leader in Influenza Vaccines | CSL Seqirus CSL Limited
Read more... -
UNIGE researchers identify how the influenza A virus manages to ... - News-Medical.Net
May 31, 2023 | 15:12 pmUNIGE researchers identify how the influenza A virus manages to ... News-Medical.Net
Read more... -
Avian Influenza A(H5N1) - United Kingdom of Great Britain and ... - World Health Organization
May 30, 2023 | 18:00 pmAvian Influenza A(H5N1) - United Kingdom of Great Britain and ... World Health Organization
Read more... -
Interim results of the effectiveness of 2022-2023 influenza vaccine ... - News-Medical.Net
May 30, 2023 | 15:44 pmInterim results of the effectiveness of 2022-2023 influenza vaccine ... News-Medical.Net
Read more... -
Influenza Vaccines Market Size to Surpass USD 11.7 Billion by 2030 ... - GlobeNewswire
May 29, 2023 | 15:30 pmInfluenza Vaccines Market Size to Surpass USD 11.7 Billion by 2030 ... GlobeNewswire
Read more... -
A Shot in the Arm for Flu Research: Integral Molecular Introduces Off ... - PR Newswire
May 23, 2023 | 14:07 pmA Shot in the Arm for Flu Research: Integral Molecular Introduces Off ... PR Newswire
Read more... -
Case Study: Pneumococcal Infection Should Be Considered After ... - Pharmacy Times
May 23, 2023 | 09:00 amCase Study: Pneumococcal Infection Should Be Considered After ... Pharmacy Times
Read more... -
Universal mRNA-Based Flu Vaccine Undergoing First Clinical Trial - ExtremeTech
May 22, 2023 | 09:00 amUniversal mRNA-Based Flu Vaccine Undergoing First Clinical Trial ExtremeTech
Read more... -
Long-sought universal flu vaccine: mRNA-based candidate enters clinical trial - Ars Technica
May 16, 2023 | 09:00 amLong-sought universal flu vaccine: mRNA-based candidate enters clinical trial Ars Technica
Read more... -
Study identifies two novel highly pathogenic avian influenza viruses ... - News-Medical.Net
May 16, 2023 | 09:00 amStudy identifies two novel highly pathogenic avian influenza viruses ... News-Medical.Net
Read more... -
The NIH is enrolling volunteers in an early-stage trial for an mRNA-based universal flu vaccine - CNN
May 16, 2023 | 09:00 amThe NIH is enrolling volunteers in an early-stage trial for an mRNA-based universal flu vaccine CNN
Read more... -
Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health - CNBC
May 15, 2023 | 09:00 amUniversal flu vaccine based on mRNA tech to be tested by National Institutes of Health CNBC
Read more... -
Clinical trial of mRNA universal influenza vaccine candidate begins - nih.gov
May 15, 2023 | 09:00 amClinical trial of mRNA universal influenza vaccine candidate begins nih.gov
Read more... -
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza ... - Novavax Investor Relations
May 9, 2023 | 09:00 amPositive Phase 2 Topline Results Show Novavax's COVID-Influenza ... Novavax Investor Relations
Read more... -
GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine - Clinical Trials Arena
May 8, 2023 | 09:00 amGSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine Clinical Trials Arena
Read more...
